Medicare Part B payment allowance limits for drugs not otherwise classified - Effective October 1, 2023 - December 31, 2023
Drug name | Dosage | Payment limit | Notes |
---|---|---|---|
Aminocaproic acid | 250 MG | 0.287 | |
Aztreonam | 500 MG | 14.712 | |
Bumetanide | 0.25 MG | 0.391 | |
Carmustine (Accord) | 100 MG | 594.083 | |
Diltiazem Hydrochloride | 5 MG | 0.342 | |
Doxycycline Hyclate | 100 MG | 15.616 | |
Famotidine | 10 MG | 0.408 | |
Flumazenil | 0.1 MG | 0.795 | |
Folic Acid | 5 MG | 2.905 | |
Furosemide (Phlow Corporation) | 20 MG | 1.579 | |
Glucarpidase | 10 UNITS | 380.699 | |
Glycopyrrolate injection | 0.2 MG | 1.345 | providers must check the crosswalk file to determine the correct payment allowance |
Glycopyrrolate injection (Fresenius Kabi) | 0.2 MG | 4.884 | providers must check the crosswalk file to determine the correct payment allowance |
Metoprolol Tartrate | 1 MG | 0.14171822859631 | |
Rifampin | 600 MG | 84.394 | |
Sodium Chloride, Hypertonic (3% - 5% infusion) | 250 CC | 1.692 | |
Sulfamethoxazole-Trimethoprim | 400-80 MG | 0.636 |